arBtrage CAPITALIZING MARKETS checking… Sign in

Eli Lilly and Company

LLY Health Care Biotechnology: Pharmaceutical Preparations
$1,131.42
▲ +0.6% Today
as of Jun 7, 07:20 ET
Last 30 days +29.45% Apr 28 → Jun 05
$828.79 $910.05 $991.32 $1072.58 $1153.84 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$1,142.97
High
$1,166.29
Low
$1,131.03
Volume
$4M
Avg Vol
$4M
Mkt Cap
$1.1T
P/E (TTM)
54.50
Beta
52w High
$1,166.29
52w Low
$623.78
Div Yield
Shares Out

Overview

52-week range
$624
$1.2K
94% of range
Avg surprise (last 1)
-5.1%
Avg reaction (last 1)
-11.7%
0% positive
Latest IV / EM
44%
EM ±4.1% · $1130 · Jun 12

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.06$2.02$4.10$6.18$8.26 Actual $1.95Actual $-0.06Actual $2.48Actual $3.28Actual $1.07Actual $3.34Est $3.52Actual $6.29Actual $6.21Actual $8.26 JunSepMarJunSepMar/2025JunSepMar
Revenue vs Net Income Revenue Net income
$0$5.2B$10.4B$15.6B$20.8B Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Mar 31, 2026Mar 2026 $8.26 financials
Tue Sep 30, 2025Sep 2025 $6.21 financials
Mon Jun 30, 2025Jun 2025 $6.29 financials
Thu May 1, 2025Mar/2025 $3.34 $3.52 -5.1% -11.7% earnings
Mon Sep 30, 2024Sep 2024 $1.07 financials
Sun Jun 30, 2024Jun 2024 $3.28 financials
Sun Mar 31, 2024Mar 2024 $2.48 financials
Sat Sep 30, 2023Sep 2023 $-0.06 financials
Fri Jun 30, 2023Jun 2023 $1.95 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$19.80B$17.60B$15.56B$12.73B$11.44B$11.30B
Cost of revenue$3.58B$3.01B$2.45B$2.23B$2.17B$2.17B
Gross profit
Operating income
Net income$7.40B$5.58B$5.66B$2.76B$970M$2.97B
EPS (diluted)$8.26$6.21$6.29$3.06$1.07$3.28

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$5.28B$7.27B$9.79B$3.38B$3.09B$3.27B$3.37B$3.22B
Inventory$14.53B$13.74B$12.18B$11.01B$9.31B$7.59B$7.46B$6.48B
Total current assets$54.84B$55.63B$62.07B$49.85B$41.26B$32.74B$31.42B$30.20B
Total assets$116.58B$112.48B$114.94B$100.92B$89.39B$78.71B$75.61B$71.87B
Long-term debt$39.37B$40.87B$40.87B$34.18B$34.50B$28.53B$29.05B$23.73B
Total liabilities
Total equity$31.20B$26.54B$23.79B$18.27B$15.76B$14.19B$14.24B$13.56B

Implied volatility — last 90 days

38%41%43%46%48% Jun 07 — IV 44% · EM ±4.1%

Sector peers